| patterns of hiv-1 and htlv-i/ii in intravenous drug abusers from the middle atlantic and central regions of the usa. | seroprevalence of human immunodeficiency virus type 1 (hiv-1) and human t lymphotropic virus types i and ii (htlv-i/ii) was determined among 1160 intravenous (iv) drug abusers from five drug treatment or medical centers (manhattan, brooklyn, new jersey, detroit, and new orleans). hiv-1 infection ranged from 5% in new orleans to 48% in new york city. hispanics and blacks had a significantly higher rate of hiv-1 infection than whites (p less than .01), but within each group rates were similar betw ... | 1990 | 2373871 |
| clinical outcomes and disease progression among patients coinfected with hiv and human t lymphotropic virus types 1 and 2. | the goal of this study was to investigate clinical outcomes and survival probabilities among persons coinfected with human immunodeficiency virus (hiv) and human t lymphotropic viruses types 1 and 2 (htlv-i/ii). a nonconcurrent cohort study of 1033 hiv-infected individuals was also conducted. sixty-two patients were coinfected with htlv-i, and 141 patients were coinfected with htlv-ii. htlv-i/ii coinfection was highly associated with african-american race/ethnicity, age of >36 years, higher cd4( ... | 2004 | 15307036 |
| retroviral coinfections at a new orleans hiv outpatient clinic. | the purpose of the study was to determine the seroprevalence of human t-lymphotropic virus types i and ii (htlv-i and htlv-ii) infections in an outpatient clinic population of human immunodeficiency virus (hiv)-1 infected persons as well as to identify the demographic and clinical characteristics and laboratory results associated with htlv-i/ii infections. during 1993-1995, 854 patients were tested for htlv-i/ii infection on entry into the clinic, of whom 25 were infected with htlv-i and 35 with ... | 1997 | 8989213 |
| high rate of htlv-ii infection in seropositive i.v. drug abusers in new orleans. | confirmed infection with htlv-ii (human t cell leukemia virus type ii) has been described only in rare cases. the major limitation to serological diagnosis of htlv-ii has been the difficulty of distinguishing htlv-ii from htlv-i (human t cell leukemia virus type i) infection, because of substantial cross-reactivity between the viruses. a sensitive modification of the polymerase chain reaction method was used to provide unambiguous molecular evidence that a significant proportion of intravenous d ... | 1989 | 2655084 |
| immunologic assessment of a cluster of asymptomatic htlv-i-infected individuals in new orleans. | although clusters of individuals infected with the human t-cell lymphotrophic virus type i (htlv-i) have been identified in the united states, no systematic evaluation of the immunologic status of these persons has been reported. we therefore studied a group of 11 htlv-i-infected former intravenous drug abusers who were long-term participants in a methadone maintenance program in new orleans, louisiana, to determine the effects of htlv-i and chronic opiate use on immunity. | 1989 | 2521277 |
| infection with human t lymphotropic virus types i and ii in sexually transmitted disease clinics in baltimore and new orleans. | patients attending sexually transmitted disease (std) clinics in baltimore (n = 4880) and new orleans (n = 1054) were surveyed in 1987 to estimate the prevalence of human t lymphotropic virus (htlv)-i/ii infection. in baltimore, 0.4% (95% confidence interval [ci], 0.2-1.1) were htlv-i/ii-seropositive and 4.9% were human immunodeficiency virus (hiv-1)-positive. in new orleans, 1.8% (ci, 1.2-2.9) of sera were htlv-i/ii-seropositive and 5.1% were hiv-1-seropositive. in both cities, htlv-i/ii preval ... | 1992 | 1569344 |